$CURI Cashflow Statement | Understand Stock

$CURI

$2.59 -$0.21 (7.5%) Close

$CURI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities
Change in fair value of warrant liability
Additions to content assets
Change in content liabilities
Amortization of content assets
Depreciation and amortization expenses
Impairment of content assets
Impairment of goodwill and intangible assets
Amortization of premiums and accretion of discounts associated with investments in debt securities, net
Stock-based compensation
Equity interests loss
Equity method investment loss
Other non-cash items

Changes in operating assets and liabilities
Accounts receivable
Other assets
Accounts payable
Accrued expenses and other liabilities
Deferred revenue
Net cash provided by operating activities
Cash flows from investing activities
Business acquisitions
Purchases of property and equipment
Investment in equity method investees
Sales of investments in debt securities
Maturities of investments in debt securities
Purchases of investments in debt securities
Net cash provided by (used in) investing activities

Cash flows from financing activities
Exercise of stock options
Exercise of warrants
Repurchases of common stock
Dividends paid
Payments related to tax withholding
Proceeds from issuance of Common Stock
Payment of offering costs
Net cash used in financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental non-cash investing and financing activities:
Acquisition of equity investment included in accrued liabilities
Supplemental disclosure:
Cash paid for taxes
Cash paid for operating leases
Right-of-use assets obtained in exchange for new operating lease liabilities

Comments